December 2014 - Cancer Currents Blog
- Which Patients Will Benefit from Immunotherapy for Cancer? Some Hints Emerge
Researchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to a form of immunotherapy called checkpoint blockade. The results could be the basis for a test that identifies likely responders to this treatment as well as for developing new treatments.
- Method for Identifying Combination Therapies to Combat Treatment Resistance Shows Promise
Researchers from the Massachusetts General Hospital Cancer Center in Boston have reported on a method for studying treatment resistance that may identify combinations of targeted therapies that can help to combat resistance in some patients.
- Building on Opportunities in Cancer Research: NCI’s Annual Plan and Budget Proposal for FY 2016
NCI’s Director, Dr. Harold Varmus, introduces the NCI Annual Plan and Budget Proposal for Fiscal Year 2016.